Genmab stock surges 11% on positive cancer drug trial data

Name: Genmab stock surges 11% on positive cancer drug trial data
Start: 2026-10-05T18:59:21.000Z
Location: Copenhagen

drug approval expired 85% Health

Genmab shares rose 11% after the company reported positive data from a cancer drug trial. The result links clinical research news with a substantial market reaction.

🇩🇰 Location: Copenhagen — Sources: 1 — First seen: 2026-10-05 — Last seen: 2026-10-05

Genmab cancer drug clinical trial positive trial data stock surge

Linked Entities

Genmab

organization involved

Contributing Articles

Genmab stock surges 11% on positive cancer drug trial data
Investing.com — 2026-10-05